Literature DB >> 6349764

A large regional hospital's experience with treatment of end-stage renal disease.

S P Handa, H K Wolf.   

Abstract

During the first 10 years of the treatment program for end-stage renal disease at the Saint John (New Brunswick) Regional Hospital 164 adults were treated by hemodialysis (with or without renal transplantation, performed outside of the province) or peritoneal dialysis. The primary causes of renal disease were not significantly different in men and women except for glomerulonephritis, which was twice as common in men as in women. Life-table analysis showed that the younger transplant recipients had the highest survival rate, but that the prognosis was almost as good among the much older patients who received continuous ambulatory peritoneal dialysis. Probably because they tended to be younger and their renal disease was caused by less threatening conditions, men survived longer than women. The survival rates were significantly related to the primary cause of the renal disease; patients with diabetes or systemic disease had the worst prognosis. Overall, these results compare well with those obtained in major university centres.

Entities:  

Mesh:

Year:  1983        PMID: 6349764      PMCID: PMC1875155     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  4 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  A computer program for comparing K samples with right-censored data.

Authors:  E T Lee; M M Desu
Journal:  Comput Programs Biomed       Date:  1972-11

3.  Results of 12 years' treatment of chronic renal failure by dialysis and transplantation.

Authors:  J D Price; K M Ashby; C E Reeve
Journal:  Can Med Assoc J       Date:  1978-02-04       Impact factor: 8.262

4.  Survival of patients treated for end-stage renal disease by dialysis and transplantation.

Authors:  M R Higgins; M Grace; J B Dossetor
Journal:  Can Med Assoc J       Date:  1977-10-22       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.